scispace - formally typeset
Open AccessJournal ArticleDOI

Immunology of COVID-19: Current State of the Science.

Nicolas Vabret, +87 more
- 16 Jun 2020 - 
- Vol. 52, Iss: 6, pp 910-941
Reads0
Chats0
TLDR
The current state of knowledge of innate and adaptive immune responses elicited by SARS-CoV-2 infection and the immunological pathways that likely contribute to disease severity and death are summarized.
About
This article is published in Immunity.The article was published on 2020-06-16 and is currently open access. It has received 1350 citations till now.

read more

Citations
More filters
Journal ArticleDOI

Cell-type-specific immune dysregulation in severely ill COVID-19 patients

TL;DR: COVID-19 patients with ARDS have a state of immune imbalance in which dysregulation of both the innate and adaptive immune responses may be contributing to a more severe disease course, as demonstrated by transcriptomic profiles indicative of defective antigen presentation and interferon responsiveness in monocytes from ARDS patients.
Journal ArticleDOI

The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19.

TL;DR: The potential role of vitamin D extra-renal metabolism in the prevention and treatment of the SARS-CoV-2 infection is summarized, helping to bring us slightly closer to fulfilling that goal.
Journal ArticleDOI

SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation.

TL;DR: This Review discusses the possible neuroimmunological mechanisms underlying the nervous system and skeletal muscle involvement, and viral triggered neuroIMmunological conditions associated with SARS-CoV-2, as well as therapeutic approaches that have been considered for these specific complications worldwide.
Journal ArticleDOI

Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants.

TL;DR: Compared to supportive care only, low-dose HCQ monotherapy was independently associated with lower mortality in hospitalized patients with COVID-19 diagnosed and treated early or later after symptom onset.
References
More filters
Journal ArticleDOI

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

TL;DR: Wang et al. as discussed by the authors used univariable and multivariable logistic regression methods to explore the risk factors associated with in-hospital death, including older age, high SOFA score and d-dimer greater than 1 μg/mL.
Journal ArticleDOI

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

TL;DR: The epidemiological and clinical characteristics of novel coronavirus (2019-nCoV)-infected pneumonia in Wuhan, China, and hospital-associated transmission as the presumed mechanism of infection for affected health professionals and hospitalized patients are described.
Journal ArticleDOI

COVID-19: consider cytokine storm syndromes and immunosuppression

TL;DR: Re-analysis of data from a phase 3 randomised controlled trial of IL-1 blockade (anakinra) in sepsis, showed significant survival benefit in patients with hyperinflammation, without increased adverse events.
Related Papers (5)